Comprehensive Corporate Update

DCM Shriram Industries Limited conducted its 35th Annual General Meeting on July 15, 2026, where shareholders approved key resolutions including a final dividend of ₹0.40 per equity share for FY 2025-26, resulting in a total payout of ₹3.48 crore. The company reported solid financial performance for FY26 with revenue of ₹1,160.12 crore and net profit of ₹41.61 crore, while maintaining a closing balance of ₹217.88 crore.

Major Business Restructuring Completed

The National Company Law Tribunal (NCLT) approved the Composite Scheme of Arrangement effective December 17, 2025, with an appointed date of April 1, 2023. The scheme involved: (i) amalgamation of Lily Commercial Private Limited with DCM Shriram Industries, transferring net assets of ₹6,271.47 lakhs, and (ii) demerger of the Chemical and Rayon businesses into wholly-owned subsidiaries DCM Shriram Fine Chemicals Limited and DCM Shriram International Limited respectively. Shareholders received 1 share each in the resultant companies for every share held in DCM Shriram as of the record date (December 26, 2025), with these shares listed on BSE and NSE from February 17, 2026.

Operational and Financial Performance

The company demonstrated improved operational metrics with sugar production of 21.11 lakh quintals (10.39% recovery rate) and distillery production of 25,172 KL of alcohol (7% increase year-over-year). Financial ratios showed significant improvement with Debt-Equity ratio declining to 1.2 (-11.5% variance), Return on Equity increasing to 11.9% (27.1% variance), and Return on Capital Employed at 19.7% (8.2% variance).

Corporate Governance and Management Changes

The AGM agenda included reappointment of directors Sunil Behari Mathur and V. Kavitha Dutt, ratification of cost auditor remuneration, and appointment of Sanjay Rastogi as Director & Chief Operating Officer. The board underwent significant changes with several directors demitting office and new appointments including independent directors Anurag Surana and Sidharth Prasad. Key managerial personnel remuneration included ₹321.60 lakh for MD & CEO Madhav B. Shriram and ₹108.78 lakh for CFO Vineet Manaktala.

Regulatory Compliance and Shareholder Matters

The company maintained strong corporate governance practices with 7 board meetings during FY25-26, full CSR expenditure of ₹79.53 lakh, and robust internal financial controls. Unclaimed dividend of ₹14.28 lakh and 132,705 equity shares were transferred to IEPF, with additional transfers scheduled for September 2026. The company's credit ratings were downgraded to CARE A- (Stable) for long-term facilities and CARE A2+ for short-term facilities. Promoter holding stood at 50.11% with 98.83% shares in dematerialized form.